Director, GMA Oncology, Antibody Drug Conjugate, Lung Cancer in Basking Ridge, NJ at DSI

Date Posted: 9/4/2020

Job Snapshot

Job Description

Join a Legacy of Innovation 110 Years and Counting!

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.

We currently have 3 Director Global Medical Affairs (GMA) roles open supporting our antibody drug conjugates (ADCs) from our ‘3 and Alpha’ Oncology R&D portfolio:
  • Trastuzumab Deruxtecan (DS-8201, brand name ENHERTUÒ), a HER2-directed ADC
  • DS-1062, a TROP2-directed ADC
  • Patritumab Deruxtecan (U3-1402), a HER3-directed ADC
Job Summary:

The Director Global Medical Affairs (GMA) Oncology, will report to the Senior Director GMA, Oncology and will support development of our Antibody Drug Conjugate (ADC) compound, with a focus on lung cancer. In this role, the Director will be responsible for assisting with the development of the compound/program medical strategies and will lead select medical affairs projects.

Responsibilities:
  • Leads the development of the GMA strategy and execution of the GMA tactical plan for lung cancer related to evidence generation, medical information and internal education, publications, scientific exchange and external data communication, and stakeholder scientific engagement.
  • Responsible for managing budgets and resources for the assigned GMA plan activities, in collaboration with GMAT Lead.
  • Leads medical readiness activities for market launches and life cycle management for lung cancer. Gains strategic and planning alignment across regions and functions and supports review of local country/regional medical affairs activities when applicable. Provide medical support/input into commercial and market access discussions.
  • Serve as medical lead for select company-sponsored GMA evidence generating studies/projects, including real world evidence (retrospective and prospective studies). Manages all medical aspects such as study document development and drives execution for assigned projects in collaboration with GMA Clinical Operations and other cross-functional and regional stakeholders.
  • Provides support in review of investigator-initiated studies (IIS) and may serve as deputy compound lead in Global IIS Review Committee meetings.
  • Collaborates cross-functionally to support Global Medical Information & Education activities such as medical information response documents, (non-) promotional materials, educational slide deck and other internal training resources, within legal and compliance regulations.
  • Provide training or communication of emerging data (internal or competitive), such as congress updates and development program highlights.
  • Provides medical leadership in interactions with key external stakeholders and lead Scientific Engagement and Exchange activities such as planning symposia, advisory boards, managing individual stakeholder interactions and peer to peer discussions, congress engagement activities, and collation of insights.
  • Provides support in the review of GMA Publications (abstracts, presentations, and manuscripts) and may serve as deputy compound lead on internal publication planning teams.
Qualifications
Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.

Required Experience and Skills
  • PhD and/or PharmD required, or MD
  • 8+ years of relevant experience; 5 years of experience within pharmaceutical industry at either local, regional and/or global level. Oncology experience highly desirable.
  • Must possess strong knowledge in and understanding of medical affairs activities relating to the commercialization of oncology products
  • Effectively manages activities and optimize resources and budget to meet business needs; have excellent project management skills
  • Build strong internal and external relationships with diverse stakeholders to maximize alignment and organizational effectiveness
  • Expertly manage ambiguity and highly complex situations
Preference Skills
  • Knowledge of ADC or other biologics, or small molecules
  • Expertise in Oncology, solid tumor, lung cancer
  • Global medical affairs experience
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.